Michael Ghadimi

Publishing 2022

Is this you? Claim this profile
3
Articles
719
Reads on Journament
20
Co-authors
3
Journals

This page collects the articles indexed under the name Michael Ghadimi. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 3

  1. Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial.
    Markus Diefenhardt, Daniel Martin, Ethan B Ludmir, Maximilian Fleischmann, Ralf-Dieter Hofheinz, Michael Ghadimi, Rebekka Kosmala, Bülent Polat, Tim Friede, Bruce D Minsky, Claus Rödel, Emmanouil Fokas
    Cancers 2022 236 reads
  2. Radiotherapy dose escalation using endorectal brachytherapy in elderly and frail patients with rectal cancer unsuitable for surgery: Lessons from studies in fit patients and future perspectives.
    Emmanouil Fokas, Robert Glynne-Jones, Maximillian Fleischmann, Pompiliu Piso, Nikolaos Tselis, Michael Ghadimi, Ralf-Dieter Hofheinz, Claus Rödel
    Cancer treatment reviews 2022 267 reads
  3. Clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) A comparison between two multicenter randomized phase II/III trials.
    Markus Diefenhardt, Maximillian Fleischmann, Daniel Martin, Ralf-Dieter Hofheinz, Pompiliu Piso, Christoph-Thomas Germer, Peter Hambsch, Robert Grützmann, Simon Kirste, Anke Schlenska-Lange, Michael Ghadimi, Claus Rödel and 1 more
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2022 216 reads

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Frequent co-authors

Publishes in